GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI
Key facts
- Who runs it
- Albert Einstein Healthcare Network
- Where
- Elkins Park, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 70 people, planned
- Started
- 19 Dec 2023
- Expected to end
- 31 Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- GetUp&Go
- GetUp&Go with 10-Week Delay
- Record updated
- 20 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Age ≥18
- TBI (open or closed), sustained at least 6 months prior to enrollment, of at least complicated-mild/moderate severity as evidenced by loss or alteration of consciousness ≥ 30 minutes; and/or post-traumatic amnesia (PTA) ≥ 24 hours, not due to intoxication/sedation and documented prospectively from the injury; and/or positive neuroimaging findings consistent with TBI
- Fully weight bearing on lower limbs and able to walk indoors and outdoors without the assistance of another person
- Cognitively able to participate in treatment as judged by ability to travel independently within the community
- Able to communicate adequately in English for participation in the treatment protocols
- Informed consent given by participant
Who cannot take part
- Planned surgery or other hospitalization during the succeeding 9 months
- Medical or psychiatric instability, including current psychosis or severe uncontrolled substance misuse, as assessed using items from the SCID/MINI/ASSIST, or suicidal ideation with intent or plan, as assessed by the Columbia-Suicide Severity Rating Scale, screening version
- Neurodegenerative disorder, e.g., Parkinson's disease
- Contraindications to increasing PA as judged by study physician, using an exam based on published screening tools
- Significant physical or intellectual disability predating the TBI
- Insufficiently inactive, i.e., reporting > 23 weekly moderate/vigorous activity units on the Godin Leisure-Time Exercise Questionnaire
- Physical or sensory disability (e.g., blindness; severe bimanual incoordination) that prevents use of a smartphone
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Traumatic brain injury
This trial is currently available in United States.
- Moss Rehabilitation Research InstituteElkins Park, United StatesContact: Amanda Rabinowitz, PhD (principal investigator)Taking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate GetUp\&Go, a program for promoting increased physical activity in individuals at least 6 months post moderate-to-severe traumatic brain injury. GetUp\&Go is a remotely delivered 10-week program that includes one-on-one sessions with a therapist and a mobile health application (RehaBot).
Read full original descriptionShow less
The main question is whether participants in the 10-week GetUp\&Go program increase their physical activity, and exhibit associated benefits in mental and physical health, relative to those who are put on a waitlist.
* Question 1: Do participants who receive immediate treatment with GetUp\&Go show more increased physical activity, measured by accelerometer activity counts per day, and improve more on secondary outcomes, such as self-reported physical activity, emotional function, fatigue, sleep, pain, and health-related quality of life, compared to their baseline, relative to those who are put on a waitlist? * Question 2: Do participants who have continued access to the mobile health component of the intervention, RehaBot, show better maintenance of physical activity gains compared to those who no longer have access to RehaBot? * Question 3: Are individual participant characteristics associated with participants' response to the treatment program?
The 2 groups in the trial
- Immediate TreatmentTreatment being tested
The 10-week GetUp\&Go intervention will be delivered entirely remotely, with 2 weekly sessions with a therapist delivered over videoconference (Zoom for Healthcare) followed by 3 sessions in weeks 3, 5, and 8, over Zoom or phone according to participant preference. The overall goal of the intervention is to develop and support a personalized plan to increase physical activity and decrease sedentary behavior, in concert with the unique capabilities, opportunities, and motivational factors of each participant. In session 2 and thereafter, RehaBot will be supplied to participants to deliver therapeutic ingredients to supplement those provided by the therapist.
Treatment: GetUp&Go
- WaitlistPlacebo, for comparison
A 10-week waitlist with baseline and outcome assessment, followed by receipt of the full GetUp\&Go program.
Treatment: GetUp&Go with 10-Week Delay
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- GetUp&Go: A Randomized Controlled Trial of a Theory-Based Intervention to Enhance Physical Activity in Chronic, Moderate-Severe Traumatic Brain Injury
- Criteria questions
- Built from NCT06028334, who can take part
- Publications
- Increasing physical activity in moderate-severe traumatic brain injury: protocol for a two-stage randomized controlled trial of a remote, mHealth-enhanced intervention.Frontiers in rehabilitation sciences, 2026
- Record updated
- 20 March 2025